News | April 19, 2010

FTC Sponsors Fibroid Awareness Week

April 19, 2010 – The Fibroid Treatment Collective (FTC) has launched an annual observance called Fibroid Awareness Week scheduled this year for April 19-23, which is dedicated to education about fibroids that affect upwards of 50 percent of all women.
Concern for the high number of unnecessary hysterectomies and dissatisfaction with other treatment outcomes led Bruce McLucas, M.D., founder of the collective and a board certified obstetrician and gynecologist, to become a non-surgical treatment advocate. His goal, and the mission of FTC, is to ensure women with fibroids know all the options when it comes to treatment. FTC advocates embolization as a safe alternative to other fibroid treatments.

In gynecology, embolization is used to reduce bleeding during uterine surgery. Founding members of the Fibroid Treatment Collective also noticed it shrinks fibroids. The promise of an effective, noninvasive treatment led to research, trials and medical acceptance. Today more than several hundred thousand women world-wide have found relief with this safe, simple procedure. The Fibroid Treatment Collective performed the very first fibroid embolization in America, and has perfected the procedure with thousands of successful treatments to date. Dr. McLucas is one of the only gynecologists in America accredited in the skills necessary to perform embolization.

Several special events will highlight the week, including a Fibroid Treatment Seminar on Wednesday, April 21 in Pasadena, Calif., at 6:00 p.m. and a national Fibroid Treatment Webinar, at 5 p.m., Friday, April 23. Both are free, and reservations can be made at www.fibroids.com.

Uterine fibroids can affect women of all ages, but are most common in women ages 40 to 50. “We felt the best way to reach out to almost half the women around the world who may have symptoms of fibroids was through an annual educational observance and to disseminate accurate and timely information about diagnosis and treatment,” said McLucas. “The Fibroid Treatment Collective was founded 12 years ago to educate women about fibroids and various treatment options,” he added.

Women interested in learning more about Fibroid Awareness Week can join a national live chat Monday through Friday from 9 a.m. - 5 p.m. PST at www.fibroids.com.

For more information: www.fibroids.com

Related Content

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Feature | Breast Density | July 05, 2017 | By Nancy M. Cappello, Ph.D.
Two decades of research on the masking risk of dense breast tissue by mammography screening is indisputable. As the...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
GE Healthcare Announces First U.S. Installation of Senographe Pristina Mammography System
News | Mammography | June 29, 2017
GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable...
Overlay Init